1937

524518

KREBSBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KREBS BIOCHEMICALS & IND Share Price Update

As of the latest trading session, KREBS BIOCHEMICALS & IND is trading at ₹65, up by ₹0.91 or 1.42% from its previous close. The stock has moved between ₹63.00 and ₹65.00 today. Over the past year, the stock has delivered a return of -15.17%. In the last month, it has returned 7.87%.

KREBS BIOCHEMICALS & IND performance

Today’s low Today’s high
₹ 63.00 ₹ 65.00
₹ 64.89
52 week low 52 week high
₹ 38.33 ₹ 113.50
₹ 64.89
Open Price ₹ 64.21
Prev. Close ₹ 64.08
Volume (Shares) 1514.00
Total traded value ₹ .98
Upper Circuit ₹ 67.28
Lower Circuit ₹ 60.88
info

Investment Returns

Over 1 Month 7.87% Over 3 Months 18.88% Over 6 Months -1.58% Over 1 Year -15.17%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KREBS BIOCHEMICALS & IND fundamentals


  • Market cap (Cr) 139.90
  • P/E Ratio (TTM) -8.22
  • Beta 1.35
  • Book Value / share -75.48
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -2.34
info icon alternate text
  • Market cap (Cr) 139.50
  • P/E Ratio (TTM) -8.22
  • Beta 1.11
  • Book Value / share -75.48
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -2.34
info icon alternate text

KREBS BIOCHEMICALS & IND Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 6.81
Operating Expense 11.15
Net Profit -2.34
Net Profit Margin (%) -34.36
Earnings Per Share (EPS) -1.09
EBITDA 1.14
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 7.27
Operating Expense 10.39
Net Profit -3.13
Net Profit Margin (%) -43.05
Earnings Per Share (EPS) -1.45
EBITDA 0.29
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 4.17
Operating Expense 10.31
Net Profit -6.14
Net Profit Margin (%) -147.24
Earnings Per Share (EPS) -2.85
EBITDA -2.79
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.48
Operating Expense 10.82
Net Profit -5.32
Net Profit Margin (%) -97.08
Earnings Per Share (EPS) -2.47
EBITDA -2.07
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 6.10
Operating Expense 14.69
Net Profit -8.27
Net Profit Margin (%) -135.57
Earnings Per Share (EPS) -3.83
EBITDA -5.06
Effective Tax Rate (%) -0.24
Particulars MAR 2026 (Values in Cr)
Revenue 23.73
Operating Expense 42.70
Net Profit -16.93
Net Profit Margin (%) -71.34
Earnings Per Share (EPS) -7.85
EBITDA -3.42
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 43.31
Operating Expense 70.94
Net Profit -26.94
Net Profit Margin (%) -62.20
Earnings Per Share (EPS) -12.49
EBITDA -14.32
Effective Tax Rate (%) -0.07
Particulars MAR 2024 (Values in Cr)
Revenue 50.42
Operating Expense 70.60
Net Profit -19.73
Net Profit Margin (%) -39.13
Earnings Per Share (EPS) -9.16
EBITDA -8.27
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 52.13
Operating Expense 77.44
Net Profit -24.69
Net Profit Margin (%) -47.36
Earnings Per Share (EPS) -11.30
EBITDA -15.16
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 59.70
Operating Expense 105.38
Net Profit -44.53
Net Profit Margin (%) -74.58
Earnings Per Share (EPS) -20.81
EBITDA -32.84
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -67.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -33.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share -55.29
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.83
EBITDA Margin -16.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share -46.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -29.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share -34.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.23
EBITDA Margin -55.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share -23.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -31.56
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 169.03
Total Liabilities 169.03
Total Equity -146.23
Share Outstanding 2
Price to Book Ratio -0.98
Return on Assets (%) -15.93
Return on Capital (%) -40.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 178.17
Total Liabilities 178.17
Total Equity -119.21
Share Outstanding 2
Price to Book Ratio -1.10
Return on Assets (%) -11.07
Return on Capital (%) -26.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 174.98
Total Liabilities 174.98
Total Equity -99.46
Share Outstanding 2
Price to Book Ratio -1.22
Return on Assets (%) -14.11
Return on Capital (%) -29.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 189.80
Total Liabilities 189.80
Total Equity -75.09
Share Outstanding 2
Price to Book Ratio -4.12
Return on Assets (%) -23.45
Return on Capital (%) -65.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 159.22
Total Liabilities 159.22
Total Equity -42.73
Share Outstanding 1
Price to Book Ratio -3.72
Return on Assets (%) -17.81
Return on Capital (%) -41.82
Particulars MAR 2025 (Values in Cr)
Net Income -26.92
Cash from Operations -7.87
Cash from Investing -4.96
Cash from Financing 12.86
Net change in Cash 0.00
Free Cash Flow -4.47
Particulars MAR 2024 (Values in Cr)
Net Income -19.72
Cash from Operations 2.36
Cash from Investing -7.81
Cash from Financing 5.50
Net change in Cash 0.05
Free Cash Flow 11.77
Particulars MAR 2023 (Values in Cr)
Net Income -24.69
Cash from Operations -24.71
Cash from Investing -12.64
Cash from Financing 37.34
Net change in Cash -0.01
Free Cash Flow -9.55
Particulars MAR 2022 (Values in Cr)
Net Income -44.52
Cash from Operations -17.21
Cash from Investing -22.89
Cash from Financing 39.50
Net change in Cash -0.61
Free Cash Flow 9.86
Particulars MAR 2021 (Values in Cr)
Net Income -28.35
Cash from Operations -14.57
Cash from Investing -22.54
Cash from Financing 37.66
Net change in Cash 0.53
Free Cash Flow 3.18
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2203.65 36.57 16.46 37331.16 2184.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

KREBS BIOCHEMICALS & IND shareholding pattern

Holding
26.75%
72.74%
0.49%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

KREBS BIOCHEMICALS & IND Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
64.89 1.26 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 63.90
  • 26 Days 60.10
  • 10 Days 62.20
  • 50 Days 59.00
  • 12 Days 61.80
  • 100 Days 59.90
  • 20 Days 60.70
  • 200 Days 64.30
65.49 PIVOT
First Support 62.59 First Resistance 66.99 Second Support 61.09 Second Resistance 69.89 Third Support 58.19 Third Resistance 71.39
RSI 58.85 ADX 25.25 MACD 1.68 Williams % R -42.35 Commodity Channel Index (CCI) 131.29
Date 2026-06-01 Week 13090.00 Same Day 4988.00 Month 9744.00
1 Year 1.36 3 Year 1.05
Over 1 Month
7.87% down
Over 1 Year
-15.17% down
Over 3 Months
18.88% down
Over 3 Years
-0.57% down
Over 6 Months
-1.58% down
Over 5 Years
-12.24% down

KREBS BIOCHEMICALS & IND Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Krebs Biochemicals & Industries Ltd?

Answer Field

Krebs Biochemicals & Industries Ltd share price is for NSE ₹ 65.00 & for BSE ₹ 64.70 as on Jun 02 2026 03:11 PM.

What is the Market Cap of Krebs Biochemicals & Industries Ltd Share?

Answer Field

The market cap of Krebs Biochemicals & Industries Ltd for NSE ₹ 139.90 & for BSE ₹ 0.00 as on Jun 02 2026 03:11 PM.

What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?

Answer Field

The 52 Week High and Low of Krebs Biochemicals & Industries Ltd for NSE is ₹ 113.50 and ₹ 38.33 and for BSE is ₹ 113.90 and ₹ 38.52.

What is 1 year return for Krebs Biochemicals & Industries Ltd?

Answer Field

The 1 year returns on the stock has been -15.17%.

What is the P/E Ratio of Krebs Biochemicals & Industries Ltd Share?

Answer Field

As on Jun 02 2026 03:11 PM the price-to-earnings (PE) ratio for Krebs Biochemicals & Industries Ltd share is -8.22.

What is the PB ratio of Krebs Biochemicals & Industries Ltd Share?

Answer Field

As on Jun 02 2026 03:11 PM, the price-to-book (PB) ratio for Krebs Biochemicals & Industries Ltd share is -75.48.

How to Buy Krebs Biochemicals & Industries Ltd Share?

Answer Field

You can trade in Krebs Biochemicals & Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Krebs Biochemicals & Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Krebs Biochemicals & Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Krebs Biochemicals & Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|